PREFILLED SYRINGE CONTAINING A GLATIRAMER ACETATE PRODUCT
The patent provides a prefilled syringe for use in treating a patient suffering from a relapsing form of multiple sclerosis, containing 1ml of an aqueous pharmaceutical solution, which has a pH in the range of 5.5-7.0, comprising 40mg/ml of glatiramer acetate and 40 mg/ml of mannitol, the prefilled...
Gespeichert in:
Hauptverfasser: | , , |
---|---|
Format: | Patent |
Sprache: | eng ; fre ; ger |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The patent provides a prefilled syringe for use in treating a patient suffering from a relapsing form of multiple sclerosis, containing 1ml of an aqueous pharmaceutical solution, which has a pH in the range of 5.5-7.0, comprising 40mg/ml of glatiramer acetate and 40 mg/ml of mannitol, the prefilled syringe prepared by the process comprising the steps of:
(i) obtaining an aqueous pharmaceutical solution of glatiramer acetate and mannitol;
(ii) filtering the aqueous pharmaceutical solution at a temperature from above 0°C up to 17.5°C to produce a filtrate; and
(iii) filling a syringe with the filtrate obtained after performing step (ii), so as to thereby prepare a prefilled syringe for use in treating a patient suffering from a relapsing form of multiple sclerosis, containing 1ml of an aqueous pharmaceutical solution, which has a pH in the range of 5.5-7.0, comprising 40mg/ml of glatiramer acetate and 40 mg/ml of mannitol. |
---|